ÖKOWORLD AG (VVV3)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 26.20 |
|---|---|
| 52-week range | 24.50 – 32.60 |
| Return, 1 month / 3 months | −2.6% / −3.3% |
| Return, 1 year / 3 years | +3.9% / +34.6% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 19.1% |
| Worst drawdown (1 year) | -13.8% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 7.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ÖKOWORLD AG is a German asset management firm based in Hilden that runs investment funds guided by environmental and social criteria. Its funds invest in companies active in areas such as renewable energy, environmental technology and sustainable business practices, and it serves private and institutional investors seeking ethical investment options. The firm manages several equity funds and markets them to savers who want their money directed toward ecological and socially responsible businesses.
The shares are listed on the XETRA Stock Exchange in Germany under the code VVV3, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ÖKOWORLD AG (VVV3) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 26.20 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 216 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.9% and over the last three months it fell 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.0% | ||
| From 52-week high | -18.9% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.3% | ||
| 6-month return | 1.6% | ||
| 12-month return, skipping the last month | 6.6% | ||
| Stability (higher is calmer) | 94 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.8% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −2.6% |
| 3 months | −3.3% |
| 6 months | +1.6% |
| 1 year | +3.9% |
| 3 years | +34.6% |
| 5 years | −64.8% |
Signals
| 50-day / 200-day average | 26.65 / 26.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.52 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | EUR 1.9700 |
| 14 Jul 2025 | EUR 2.4100 |
| 8 Jul 2024 | EUR 2.2200 |
| 22 Jun 2023 | EUR 2.2200 |
| 27 Jun 2022 | EUR 2.2200 |
| 5 Jul 2021 | EUR 1.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.